Large-scale testing (Phase 3)Looking for participantsNCT06674148
What this trial is testing
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Qifangfeixian Granules in the Treatment of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD)
Who this might be right for
Interstitial Lung DiseaseQifangfeixian Granules
Huilan Zhang 124